4.5 Article

Clinical presentation and long-term outcomes of infantile hypertrophic cardiomyopathy: a European multicentre study

期刊

ESC HEART FAILURE
卷 8, 期 6, 页码 5057-5067

出版社

WILEY PERIODICALS, INC
DOI: 10.1002/ehf2.13573

关键词

Infant-onset; Hypertrophic; Cardiomyopathy; Prognosis

资金

  1. British Heart Foundation [FS/16/72/32270]
  2. Association for European Paediatric and Congenital Cardiology (AEPC junior grant)
  3. Max's Foundation
  4. Great Ormond Street Hospital Charity
  5. Great Ormond Street Hospital for Children
  6. Medical Research Council (MRC) Clinical Academic Research Partnership (CARP) award
  7. NIHR GOSH BRC
  8. Children's Memorial Health Institute [S176/2018]

向作者/读者索取更多资源

This study focused on infantile hypertrophic cardiomyopathy patients from multiple European centers, revealing a complex and diverse cohort with regards to etiology, phenotype, and clinical course. While overall outcomes were poor, it was primarily related to the underlying etiology, stressing the importance of comprehensive etiological investigations.
Aims Children presenting with hypertrophic cardiomyopathy (HCM) in infancy are reported to have a poor prognosis, but this heterogeneous group has not been systematically characterized. This study aimed to describe the aetiology, phenotype, and outcomes of infantile HCM in a well-characterized multicentre European cohort. Methods and results Of 301 children diagnosed with infantile HCM between 1987 and 2019 presenting to 17 European centres [male n = 187 (62.1%)], underlying aetiology was non-syndromic (n = 138, 45.6%), RASopathy (n = 101, 33.6%), or inborn error of metabolism (IEM) (n = 49, 16.3%). The most common reasons for presentation were symptoms (n = 77, 29.3%), which were more prevalent in those with syndromic disease (n = 62, 61.4%, P < 0.001), and an isolated murmur (n = 75, 28.5%). One hundred and sixty-one (53.5%) had one or more co-morbidities. Genetic testing was performed in 163 (54.2%) patients, with a disease-causing variant identified in 115 (70.6%). Over median follow-up of 4.1 years, 50 (16.6%) underwent one or more surgical interventions; 15 (5.0%) had an arrhythmic event (6 in the first year of life); and 48 (15.9%) died, with an overall 5 year survival of 85%. Predictors of all-cause mortality were an underlying diagnosis of IEM [hazard ratio (HR) 4.4, P = 0.070], cardiac symptoms (HR 3.2, P = 0.005), and impaired left ventricular systolic function (HR 3.0, P = 0.028). Conclusions This large, multicentre study of infantile HCM describes a complex cohort of patients with a diverse phenotypic spectrum and clinical course. Although overall outcomes were poor, this was largely related to underlying aetiology emphasizing the importance of comprehensive aetiological investigations, including genetic testing, in infantile HCM.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据